Brazil seeking to import 20 million doses of India’s Covaxin vaccine – ANVISA

RIO DE JANEIRO, BRAZIL – (REUTERS) Brazil’s health ministry has applied for authorization to import 20 million doses of the Covaxin/BBV152 COVID-19 vaccine, manufactured in India, where the vaccine is authorized for emergency use, health agency ANVISA said on Tuesday, May 25.

The ministry had filed a previous request that was denied by the agency.

Related coverage: Indigenous leaders reject Bolsonaro's impending visit to Yanomami land · Brazil's meat industry warns of rising prices and calls for government tax breaks · Panama accumulates 374,356 cases of Covid-19 and 6,346 deaths (May 24) · Bolsonaro's "chloroquine guru" Arthur Weintraub enters Brazil's Covid CPI sights

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Brazil runoff, Sunday, October 25: Brazil runoff: date, poll closing times and when results start. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.